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Background: Neutrophil extracellular traps (NETs) composed of DNA and proteins form a scaffold in thrombi, supple-
menting the fibrin matrix.
Results: DNA and histones modify the structure of fibrin and render it resistant to mechanical and enzymatic destruction.
Conclusion: NET components are essential factors in thrombus stability.
Significance: Therapeutic strategies could be optimized to enhance fibrinolysis in clots containing DNA and histones.
Neutrophil extracellular traps are networks of DNA and asso-
ciated proteins produced by nucleosome release from activated
neutrophils in response to infection stimuli and have recently
been identified as key mediators between innate immunity,
inflammation, and hemostasis. The interaction of DNA and his-
tones with a number of hemostatic factors has been shown to
promote clotting and is associated with increased thrombosis,
but little is known about the effects of DNA and histones on the
regulation of fibrin stability and fibrinolysis. Here we demon-
strate that the addition of histone-DNA complexes to fibrin
results in thicker fibers (increase inmedian diameter from 84 to
123 nm according to scanning electron microscopy data)
accompanied by improved stability and rigidity (the critical
shear stress causing loss of fibrin viscosity increases from 150 to
376 Pawhereas the storagemodulus of the gel increases from 62
to 82 pascals according to oscillation rheometric data). The
effects of DNA and histones alone are subtle and suggest that
histones affect clot structure whereas DNA changes the way
clots are lysed. The combination of histones  DNA signifi-
cantly prolongs clot lysis. Isothermal titration and confocal
microscopy studies suggest that histones and DNA bind large
fibrin degradation products with 191 and 136 nM dissociation
constants, respectively, interactions that inhibit clot lysis. Hep-
arin, which is known to interfere with the formation of neutro-
phil extracellular traps, appears to prolong lysis time at a con-
centration favoring ternary histone-DNA-heparin complex
formation, and DNase effectively promotes clot lysis in combi-
nation with tissue plasminogen activator.
Neutrophil extracellular traps (NETs)2 are networks of DNA
decorated with histones and other proteins, proteases, and
other antimicrobial factors (1). They are produced when neu-
trophils, basophils, or mast cells release nucleosomes after
stimulation by inflammatory cytokines or LPS for example (1)
or by interaction with platelets after stimulation of platelet toll-
like receptors 4 and 2 by microbial structures (2, 3). It is pro-
posed that NET formation is the first line of defense of the
innate immune system, providing an effective way of trapping
pathogenic microbes and removing them from the circulation
(4).
The DNA and histones of NETs provide a scaffold for cell
localization (including neutrophils and red blood cells), platelet
aggregation, and activation that serves to promote coagulation
and thrombosis (5). Thus, NETs are a focus of significant cross-
talk between innate immunity, inflammation, and hemostasis,
and there are many points of contact including bidirectional
interactions with platelets, inflammatory cytokines (IL-8),
fibrinogen, fibronectin, von Willebrand factor, tissue factor
pathway inhibitor, protein C, thrombomodulin, factor XII, and
neutrophil-derived serine proteases (3–6). HistonesH3 andH4
have been identified as critical players andmediators of damage
able to stimulate phosphatidylserine exposure and factor Va
expression on platelets and interact with polyphosphates to
promote clotting even in the absence of factor XII (3). Histones
may come from NETs or dying cells and are implicated in the
progression of sepsis. Stimulation of coagulation by NETs can
result in unwanted thrombosis (7), and infection is a common
event in the development of deep vein thrombosis (8, 9). Tar-
geting the release of nucleosomes, development of NETs, and
availability of circulating histones could be a strategy for pre-* This work was supported by Wellcome Trust Grant 083174, Hungarian Sci-
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demic Exchange Service Grant DAAD A/12/01760.
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vention or therapeutic intervention for venous thromboembo-
lism, sepsis, and other diseases involving cell death and lysis.
However, although there are extensive studies on the inter-
action between NET components and coagulation, little is
known about the effects of DNA and histones on fibrinolysis.
Bacterial infection by Streptococcus and Staphylococcus spp. is
accompanied by secretion of plasminogen-binding and activat-
ing proteins as the bacteria hijack the host fibrinolytic system
(10, 11). Streptokinase is a classic example of a plasminogen
activator from streptococci, and staphylokinase is produced by
staphylococci. Interestingly, streptococci also release a DNase,
streptodornase, which is linked to bacterial virulence (12),
suggesting that streptokinase and streptodornase can work
together to break down fibrin clots and NETs and promote
bacterial dissemination. DNases have been shown to degrade
NETs and prevent platelet adhesion and activation (5) and to
prevent thrombosis in in vivomodels (2, 13).
Systemic infection triggers coagulation and an immune
response involving neutrophils andNETs that work together to
restrict the movement of microorganisms within the vascula-
ture and at the same time promote thrombin generation and
thrombosis. As suggested previously (5), it is important to
understand the effects that DNA and histones might have on
fibrin structure andmechanical properties and the implications
for fibrinolysis, thrombus breakdown, and embolism. These
topics are the subject of the current study with the main focus
on the endogenous fibrinolysis system regulated by tissue plas-
minogen activator (tPA).
EXPERIMENTAL PROCEDURES
Generation and Purification of tPA Variants and Other
Activators—tPAwasmodified to express a C-terminal fusion of
enhanced green fluorescent protein using pFastBac-tPA (and
derivatives) as described previously (14).
Fibrinolysis Kinetics Methods—Plasminogen activation and
fibrin lysis assays were performed as described previously (15)
to measure the effect of DNA and histones on clot formation
and lysis in microtiter plates by mixing equal volumes of solu-
tions of (a) thrombin, tPA, and DNA (where present) with (b)
fibrinogen, plasminogen, and histones (where present) to give a
100-l reaction mixture of 25 nM thrombin, 70 pM tPA, 8 M
fibrinogen, and ranges of DNA and histone concentrations.
Where heparin was present in reaction mixtures (over a range
of concentrations shown under “Results”), it was added first to
reaction wells followed by solution a and then solution b.
Fibrinogen and DNA (calf thymus) were from Calbiochem;
plasminogen was from Hyphen-Biomed, Neuville-sur-Oise,
France; histones (calf thymus, type IIIS) were from Sigma-Al-
drich; and-thrombin (01/580), tPA (98/714), and heparin (07/
328) were from the National Institute for Biological Standards
and Control, SouthMimms, UK. Selectable endpoints for anal-
ysis (such as clotting maximum absorbance, time to clotting
maximumabsorbance, time to 50% lysis, time to 100% lysis, and
time to 50% lysis from clotting maximum) were extracted from
absorbance versus time data and analyzed using bespoke soft-
ware written using the free statistical software package R (16)
(script available on request). tPA activity was also determined
in tubes by mixing 200 l of a solution of histones (50 g/ml),
thrombin (30 nM), and tPA with 1.0 ml of fibrinogen (1.3
mg/ml), plasminogen (200 nM), andDNA (70g/ml) (final con-
centrations given) and monitoring the collapse of clots by
release of bubbles (17). tPAwas present at 0.4, 0.2, and 0.1 nM so
potency relative to conditions without DNA and histones and
95% confidence limits could be calculated using parallel line
bioassaymethods (17). Time lapse videos of lysis were prepared
under the same conditions with 0.2 nM tPA by following the
reactions for 2–3 h. DNase I was fromThermo Scientific, Rock-
ford, IL.
Scanning Electron Microscope (SEM) Imaging of Thrombi
and Fibrin—Immediately (within 5 min) after surgery or the
preparation of fibrin, 5 5 10-mmpieces of thrombi or fibrin
clots of 100-l volume were placed into 10 ml of 100 mM
sodium cacodylate, pH 7.2 buffer for 24 h at 4 °C. Following
repeated washes with the same buffer, samples were fixed in 1%
(v/v) glutaraldehyde for 16 h. The fixed samples were dehy-
drated in a series of ethanol dilutions (20–96% (v/v)), a 1:1
mixture of 96% (v/v) ethanol/acetone, and pure acetone fol-
lowed by critical point drying with CO2 in an E3000 Critical
Point Drying Apparatus (Quorum Technologies, Newhaven,
UK). The specimens were mounted on adhesive carbon discs
and sputter-coated with gold in an SC7620 Sputter Coater
(Quorum Technologies), and images were taken with scanning
electron microscope EVO40 (Carl Zeiss GmbH, Oberkochen,
Germany).
Immunohistochemistry—After surgery, the removed throm-
bus samples were frozen immediately at 70 °C and stored
until examination. Cryosections (6-m thickness) of thrombi
were attached to lysine-coated slides. Sections were fixed in
acetone at 4 °C for 10 min and air-dried for 5 min at room
temperature followed by incubation in 100 mM sodium phos-
phate, 100 mM NaCl, pH 7.5 buffer (PBS) containing 5% (w/v)
bovine serum albumin to eliminate nonspecific binding of anti-
bodies. Subsequently, slides were washed in PBS three times,
andDNAwas stainedwith the dimeric cyanine nucleic acid dye
TOTO-3 (T-3604, Invitrogen; excitation, 640 nm, emission,
660 nm) at 1:5000 dilution with PBS containing 10% glycerol
and 0.02% Tween 20 for 15 min followed by three washes in 50
mM Tris-HCl, 100 mM NaCl, 0.02% (w/v) NaN3, pH 7.4 buffer
(TBS). For double immunostaining, the sections were incu-
bated with 2 g/ml mouse monoclonal anti-human fibrin anti-
body (ADI313, American Diagnostica, Pfungstadt, Germany)
and 2 g/ml rabbit anti-human histone H1 antibody (Sigma-
Aldrich) in TBS. Following washing with TBS, sections were
treated with Alexa Fluor 488 (excitation, 495 nm; emission,
519 nm) goat anti-mouse immunoglobulin antibody (Invitro-
gen) at 1:100 dilution and Alexa Fluor 546 (excitation, 556 nm;
emission, 573 nm) goat anti-rabbit immunoglobulin antibody
(Invitrogen) at 1:100 dilution. Following three washes, glass
coverslips were affixed over a drop of 50% (v/v) glycerol in TBS.
Confocal fluorescence imageswere taken using a Zeiss LSM510
confocal laser scanning microscope equipped with a 20 1.4
objective (Carl Zeiss GmbH, Jena, Germany) at 488-nm excita-
tion laser line (20% intensity) and emission in the 500–530-nm
wavelength range, 543-nm excitation laser line (100% intensity)
and emission in the 565–615-nm wavelength range, 633-nm
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excitation laser line (100% intensity) and emission in the range
over 650-nm wavelength.
Isothermal Titration Calorimetry (ITC)—Enthalpy changes
accompanying the interaction of DNA and proteins (fibrin deg-
radation products (FDPs), fibrinogen, histones, and plasmino-
gen) were measured using an isothermal titration method on a
VP-ITCmicrocalorimeter (MicroCal Inc., Northampton,MA).
The proteins were injected in a series of 25 aliquots (10l each)
into the cell of the calorimeter containing DNA or protein, and
the heat increment of each additionwas recorded by the instru-
ment. Dilutions of protein into buffer were carried out in a
separate series of injections, and these heat increments were
subtracted from the raw data. Heat data for the interactions
were evaluated according to the single site algorithm with ITC
Data Analysis version 7.0 software (MicroCal Inc.). For the cal-
culation of equilibrium parameters, the mass concentration of
DNA was converted to molar concentration of nucleotides
using an average molecular mass of 500 Da. Themolar concen-
tration of the FDPs of 150 kDa or larger was estimated from the
mass concentration and densitometric data of the polyacryl-
amide gel electrophoretic (PAGE) pattern of the FDPs used for
the binding experiments.
Preparation of FDPs—Clotting of fibrinogen (human, plas-
minogen-depleted; Calbiochem) and fibrinolysis were initiated
simultaneously with thrombin (90 nM) and plasmin (5 nM). The
final concentration of fibrinogen was 6 M for preparation of
extensively degraded products of fibrin digestion and 12M for
partial digestion and generation of large FDPs. Plasmin action
was stopped by the addition of 4-(2-aminoethyl)benzenesulfo-
nyl fluoride (Pefabloc from Roche Applied Science) at a final
concentration of 0.05 mM immediately after a steel ball placed
on the surface of the clot reached the bottom of the tube
(16–18 h after the start of lysis). For more extensive degrada-
tion Pefabloc was added 2–4 h later when the visible fibrin gel
had totally disappeared. The fluid phases were withdrawn from
each of the tubes after centrifugation at 6000 g for 5min, and
the total protein contents were determined from the values of
absorbance of the supernatants at 280 nm (A280 of 1.6 corre-
sponds to 1 g/liter non-clottable fibrin degradation products
measured under identical conditions (18)). The supernatant
was subjected to SDS electrophoresis on a 4–15% polyacryl-
amide gel under non-reducing and reducing conditions and
silver-stained. Concentrations of large degradation fragments
(over 150 kDa) were calculated as a fraction of total protein
based on quantitative gel analysis using SigmaGel software
(Jandel Scientific, Erkrath, Germany).
Confocal Microscopy Imaging—Fibrin clots were prepared
from 6 M fibrinogen, 2% of which was Alexa Fluor 546-conju-
gated fibrinogen (Invitrogen), and 1.5 M plasminogen clotted
with 16 nM thrombin for 30min at room temperature in sterile,
uncoated Ibidi VI 0.4 -Slides (Ibidi GmbH, Martinsried, Ger-
many). In certain cases, 50 or 100g/ml DNA (human; isolated
from granulocytes) and/or 3.45 M histone IIIS (from calf thy-
mus; Sigma-Aldrich) was also added to themixture. Thereafter,
4 g/ml tPA-GFP was added to the edge of the clot, and the
fluorescence (excitation wavelength, 488 nm; emission wave-
length, 525 nm for tPA-GFP detection; excitation wavelength,
543 nm; emission wavelength, 575 nm for Alexa Fluor 546-
fibrinogen detection)wasmonitoredwithConfocal Laser Scan-
ning SystemLSM510 (Carl ZeissGmbH, Jena, Germany) taking
sequential images of the fluid-fibrin interface at a distance of
50 m from the glass surface with identical exposures and
laser intensities using a Plan-Neofluar20/0.5 objective.
Preparation of Neutrophil DNA—Neutrophil granulocytes
were isolated from the buffy coat fraction of human blood
(Hungarian Blood Supply Service, Budapest, Hungary) (19)
according to a procedure described previously (20). Following
cell lysis, DNA was extracted using 25:24:1 phorbol/chloro-
form/isoamyl alcohol reagent (Sigma-Aldrich); precipitated
out of the water phase in 0.3 M sodium acetate, pH 5.2 buffer
and 96% (v/v) ethanol; and resuspended in 25 mM NaH2PO4/
Na2HPO4, pH 7.4 buffer containing 75 mM NaCl. The ratio of
absorbance at 260 and 280 nm was 1.88–1.95 in the final prep-
aration. The concentration of DNA was determined from
absorbance at 260 nm using calf thymus DNA (Calbiochem) as
a reference.
Evaluation of Fibrin Rigidity—140l of 10 mg/ml fibrinogen
was premixed with 60 or 120 l of 0.5 mg/ml DNA and supple-
mented with 10 mM HEPES, pH 7.4 buffer containing 150 mM
NaCl to a 500-l final volume. Clotting was initiated with 50l
of 100 nM thrombin added to 410l of fibrinogen solution, and
410l of the clottingmixture was transferred to the plate of the
HAAKE RheoStress 1 oscillation rheometer (Thermo Scien-
tific, Karlsruhe, Germany) thermostatted at 37 °C. The cone
(titanium, 2° angle, 35-mm diameter) of the rheometer was
brought to the gap position, and a shear strain () of 0.015 was
imposed exactly at 2 min after the addition of thrombin. Mea-
surements of storage modulus (G) and loss modulus (G) were
taken at 1 Hz in the course of 15 min with HAAKE RheoWin
data manager software v. 3.50.0012 (Thermo Scientific,
Karlsruhe, Germany) (21). Following this 15-min clotting
phase, determination of the flow limit of fibrin gels was per-
formed in the same samples by increasing the applied shear
stress () from 0.01 to 500.0 pascals stepwise in 150 s, and the
resulting strainmeasuredwas used for calculation of the viscos-
ity modulus (the critical shear stress 0 determined by extrapo-
lation of the decline in viscosity to 0 that was used as an indica-
tor of the gel/fluid transition in the fibrin structure).
Structural Characterization of Fibrin by Small Angle X-ray
Scattering (SAXS)—Fibrin samples with the same composition
as those used for the evaluation of rigidity and additional sam-
ples containing unfractionated heparin were also examined by
SAXS measurements performed on the four-crystal mono-
chromator beamline of Physikalisch-TechnischeBundesanstalt
(PTB) (Berlin, Germany) supplemented by the SAXS setup of
Helmholtz-Zentrum Berlin (HZB German Patent DE 2006 029
449) at the synchrotron radiation facility BESSY II (HZB, Berlin,
Germany) (22). The samples were filled into glass capillaries
with 1.0-mm diameter. The energy of the incoming x-ray beam
was 7 keV, and the two-dimensional scattering patterns were
collected with a gas-filled area detector. Measurements were
performed at sample-to-detector distances of 1.4 and 4 m to
cover the range of momentum transfer of q 0.7–3 nm1 (q
4/ sinwhere  is half the scattering angle and  is the wave-
length of the incident x-ray beam). All measurements were car-
ried out at room temperature. The scattering curves were
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obtained by radial averaging of the two-dimensional patterns
using SASREDTOOL program v. 1.2 (Sylvio Haas, Helmholtz-
Zentrum, Berlin, Germany). For quantitative analysis of the
scattering pattern, non-linear least square fitting of an empiri-
cal model function to the scattering curves was performed
using SASfit program v. 0.93.3 (Joachim Kohlbrecher and Ingo
Bressler, Paul Scherrer Institute, Villigen, Switzerland) in
which the peaks were approximated by Lorentzian functions
and the decay trend was taken into account by different power
law functions.
Statistical Procedures in Morphometric Analysis—The SEM
images of fibrin were analyzed to determine the diameter of the
fibrin fibers using self-designed scripts running under Image
Processing Toolbox v. 7.0 of Matlab 7.10.0.499 (R2010a) (The
Mathworks, Natick,MA) (23). For the diametermeasurements,
a grid was drawn over the image with 10–15 equally spaced
horizontal lines, and all fibers crossed by themwere included in
the analysis. The diameters weremeasured bymanually placing
the pointer of the Distance tool over the end points of trans-
verse cross-sections of 300 fibers from each image (always per-
pendicularly to the longitudinal axis of the fibers). Two images
of two independent samples were analyzed in a single global
procedure. The distribution of the data on fiber diameter was
analyzed using an algorithm described in detail previously (23)
where theoretical distributions were fitted to the empirical data
sets and compared using the Kuiper test andMonte Carlo sim-
ulation procedures.
RESULTS
Thrombi from Patients—Little is known about the distribu-
tion of DNA and histones in thrombi found in patients. Fig. 1
shows staining for DNA and histones found in three represent-
ative thrombi recovered from patients. There was variable but
widespread staining for DNA. Histones were also present
although not so widely dispersed and in some cases were coin-
cident with fibrin aggregates. The thrombi rich in red blood
cells (Fig. 1, TO) or in fibrin (GI) according to the SEM images
showed limited DNA- and histone-positive regions in contrast
to the extensively stained areas in the leukocyte-rich (TJ)
thrombus.
Fibrin Structure in Purified Systems—Further detailed anal-
ysis of fibrin structure and the kinetics of clotting and lysis was
performed using a simple model system of purified proteins.
When fibrinogen was clotted in the presence of DNA and/or
histones, morphometric analysis of SEM images showed signif-
icant changes in fibrin fiber diameter as summarized in Table 1.
Statistical analysis of fibrin fiber diameter was performed, and
probability density distributionswere calculated, for fibrin clots
with no additions or with DNA and/or histones as indicated in
Table 1. The general trend apparent from these studies was that
DNA alone produced small effects on fibrin structure, whereas
in the presence of histones or DNA histones, the fibrin fiber
thickness increased.
The SEM data characterize the protein content of individual
fibrin fibers, but this technique cannot resolve nanometer-scale
structure of fibrin in its natural hydrated state. Small angle
x-ray and neutron scattering proved to be a powerful tool in the
characterization of the longitudinal arrangement of the mono-
mers in the protofibrils and the lateral alignment of protofibrils
in fibers (24). The general decay trend of the scattering curves
(Fig. 2) reflects the fractal structure of the fibrin clot, and its
effect can be modeled as a background signal with empirical
power law functions in the form of C0  C4  q for clots
containing fibrin, DNA, and heparin orwith an additional func-
tion with a fixed exponent of 1 for samples with histones
(supplemental table). The peaks arising above this background
reflect the longitudinal and cross-sectional alignment of fibrin
monomers. A small but sharp peak in pure fibrin at a q value of
0.285 nm1 (Fig. 2 and supplemental table, Peak 2) corre-
sponds to a longitudinal periodicity of d  2/q  22 nm,
which is in agreement with earlier SAXS studies (24) and a little
bit lower than the values reported for dried samples in trans-
mission electronmicroscopy investigations (25). This peak can-
not be resolved in fibrin containing DNA or heparin, indicating
that these additives disrupt the regular longitudinal alignment
of the monomeric building blocks. In contrast, the addition of
histone does not interfere with the longitudinal periodicity, and
the related scattering peak is evenmore pronounced (Fig. 2 and
supplemental table). In pure fibrin, two additional broad scat-
tering peaks can be resolved, spanning over the q ranges of
0.2–0.5 and0.6–1.5 nm1 (supplemental table, Peak 1 and
Peak 3, respectively). The first peak can be attributed to a peri-
odicity of 12.5–31 nm in cluster units of the fibers, whereas
FIGURE 1. Fibrin, histone, andDNA content of arterial thrombi. Following
thrombectomy, thrombus sampleswere either frozen for immunostaining or
washed, fixed, and dehydrated for SEM processing as detailed under “Exper-
imental Procedures.” Sections of frozen samples were doubly immuno-
stained for fibrin (green) and histone 1 (red) aswell aswith aDNAdye, TOTO-3
(blue). Images were taken at an original magnification of20with a confocal
lasermicroscope. SEM imageswere taken from the fixed samples of the same
thrombi. TO, a thrombus frompopliteal artery;GI, a thrombus from infrarenal
aorta aneurysm; TJ, a thrombus from femoropopliteal graft. Scale bars, 2 m
in SEM panels and 50 m in all other panels.
TABLE 1
Effect of DNA and histones on fiber diameter in composite fibrin net-
works
SEM images of fibrin clots prepared from 6 M fibrinogen and the indicated addi-
tives and clotted with 30 nM thrombin were used for the measurement of fiber
diameter as described previously (14). The fiber size is reported in nmasmedian and
bottom-top quartile values (in parentheses) of the theoretical distributions fitted to
the measured diameter values (data from four SEM images with 300 measured
diameters in each). H1, histone 1.
No DNA
50 g/ml
DNA
100 g/ml
DNA
No H1 84 (64–110) 94 (74–120) 92 (76–111)
50 g/ml H1 119 (91–154) 122 (97–153) 114 (92–140)
100 g/ml H1 108 (88–132) 122 (93–157) 123 (98–149)
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the second peak corresponds to a periodicity of 4–10 nm
characteristic for the average protofibril-to-protofibril distance
based on the structural models of Yang et al. (26) and Weisel
(25). Both of these broad peaks are most profoundly affected by
the presence of histone (a 10-fold decrease in the area of Peak 1
and complete loss of Peak 3; supplemental table), suggesting
that this additive interferes with the lateral organization of
protofibrils, resulting in lower protofibril density. Earlier stud-
ies (27) have shown that lower protofibril density can corre-
spond to thicker fiber diameter, which is in qualitative agree-
ment with our SEM results (Table 1). The structure-modifying
effects of histone are preserved in the presence of DNA, but
these effects are completely reversed in the quaternary system
of fibrin/DNA/histone/heparin (Fig. 2).
Further evidence that DNA and histones can affect the
behavior of fibrin clots was obtained from rheology studies.
Fibrin clots were formed to contain pure fibrin or 50 or 100
g/ml DNA, and the effect of added histones (300 g/ml) was
also investigated. The most striking differences seen in rheol-
ogy parameters were in the shear stress necessary to disassem-
ble the fibrin as presented in Fig. 3 where two opposing effects
are clearly demonstrated. In the presence of DNA alone, the
curves can be interpreted as increased sensitivity of fibrin to
mechanical shear so that the shear force needed to disassemble
fibrin (where viscosity approaches 0) is reduced in comparison
with the situation without DNA. However, when histones are
added to fibrin and to a greater extent when histones are added
to fibrinDNA, the clots becomemore stable and resistant to
shear forces. Similarly, the softening of the fibrin caused by
DNA (decrease in the storage modulus G; see Table 2) was
reversed by the addition of histones. The changes in the loss
modulus G followed the trend of the storage modulus G, but
DNA on its own did not alter their ratio, whereas the presence
of histones resulted in a relatively greater increase in the loss
modulus, indicating a fibrin structure that dissipates more
energy during deformation (presumably due to more signifi-
cant rearrangements in fibrin protofibrils or fibers (see Ref. 21).
Fibrinolysis—tPA-catalyzed fibrinolysis was monitored in
several systems to investigate the effects of DNA and histones.
Fibrin turbidity was monitored in a microtiter plate format,
providing information on clotting and lysis. In agreement with
the morphometric analysis, adding a range of DNA concentra-
tions alone to a clot resulted in small changes in clot turbidity
with minor increases in lysis times (assessed as times to 50 and
100% lysis) as shown in Fig. 4A. The apparent potency of tPA
when assessed over a range of tPA concentrations (5–40 ng/ml)
is reduced by 15–20% at an optimal DNA concentration of 0.25
mg/ml. When histones were incorporated into clotting fibrin,
there appeared to be more significant changes in fibrin struc-
ture as shown by maximum turbidity and fibrinolysis as shown
in Fig. 4B. Time tomaximumabsorbance changed from1400 to
1000 s at 0.04–0.1 mg/ml histones, and time to 50% lysis was
apparently extended from around 2000 to 4000 s as histone
concentration increased up to 1.0 mg/ml. The combination of
both DNA and histones had a marked effect on clot lysis pro-
files as can be seen in Fig. 4Cwhere curves for 0, 0.04, 0.33, and
1 mg/ml histones all in the presence of 0.03 mg/ml DNA are
shown. The typically smooth, reproducible lysis curves seen
without DNA or histones or with DNA or histones individually
became highly variable when DNA and histones were added
together. Clots could takemany hours to be lysed completely. A
differentmethod that does not rely on clot turbidity was used to
assess the apparent potency of tPA under similar conditions
(17). Setting tPA activity in the absence of DNA or histones to
100%, the relative activity (and 95% confidence intervals) with
additions was 85.4% (78.8–92.6%) with 70 g/ml DNA and
146.8% (138.6–155.5%) with 50g/ml histones. The potency of
tPA in the presence of both DNA and histones could not be
determined as this method relies on identifying the collapse of
the fibrin clot and release of trapped bubbles, but this end point
FIGURE 2. Small angle x-ray scattering of fibrin clots containing 100
g/ml DNA, 300g/ml histone, 10 IU/ml heparin, or their combinations
at the same concentrations. Curves are shifted vertically by the factors indi-
cated at their origin for better visualization. Symbols represent the measured
intensity values, and solid lines show the fitted empirical functions as
described in the supplemental table. The dashed vertical line indicates the
longitudinal periodicity of about 22 nm, and the solid vertical lines show the
boundaries of the broad peaks that characterize the lateral structure of
the fibrin fibers.
FIGURE 3. Rheology studies showing the effect of DNA, histones, and
DNA-histone on the critical shear stress needed to disassemble fibrin.
Curves are shown for pure fibrin (red), fibrin containing 50g/mlDNA (green),
and 100 g/ml DNA (magenta). The addition of histones leads to increased
clot stability under sheer stress shown in the presence of 300 g/ml histone
(blue) and 300 g/ml histone 100 g/ml DNA (black). Pa, pascals.
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was highly variable and subjective in the presence of both DNA
and histones, mirroring the pattern seen in Fig. 4C.
The profound effect of DNA and histones on clot lysis in this
system is illustrated in Fig. 5 and the accompanying time lapse
videos (supplemental Videos 1 and 2). The consistent pattern
observed was that clots were initially more opaque but were
lysed more quickly in the presence of 50 g/ml histones (tube
2); complete lysis was slightly delayed in the presence of 70
g/ml DNA (tube 3). However, the onset of observable changes
within the clot was not delayed by the presence of DNA, but the
fibrin structure held together longer. Tube 5 shows a much
delayed lysis in the presence of DNA histones accompanied
by heterogeneous clot formation and lysis. Tube 6 demon-
strates how5units/mlDNase I could reverse some of the effects
of DNA histones whenmixed with the forming clot (Fig. 5A)
or when DNA was pretreated with DNase I for 30 min before
clotting (Fig. 5B). Control clots without tPA were stable for
days, indicating that lysis was not affected by contaminating
proteases in the DNA or histone preparations.
To focus on the microscopic behavior of tPA during clot
lysis, we used confocal microscopy in conjunction with green
fluorescent protein fusions of tPA (tPA-GFP) with fluores-
cently modified fibrinogen (14). Results are summarized in Fig.
6. The top row shows the typical pattern (14) in which fibrinol-
ysis is accompanied by the generation of fibrin aggregates near
the clot surface around the lysis front that strongly bind tPA-
GFP. The second row with the addition of DNA shows some
fibrin aggregate formation but strikingly a diffuse clot structure
that remains behind the advancing tPA-GFP front. The lower
two rows both containing histones show further changes in
binding and fibrinolysis, primarily suggesting much poorer
binding of tPA-GFP even though there is fibrin aggregate for-
mation. Nevertheless, measurements of the rates of movement
of the tPA-GFP front through fibrin show that although DNA
may impede clot lysis, histones with or without DNA speed up
the advance of the lysis front.
Binding Studies on Fibrin Degradation Products and DNA—
Given the apparent widespread distribution of DNA in thrombi
noted in Fig. 1 and the suggestion from Fig. 6 that fibrin clot
structure and the behavior of aggregates formed from FDPs are
affected by the presence of DNA and/or histones, further stud-
ies were performed to investigate the interactions between
TABLE 2
Rigidity and viscoelastic parameters of composite fibrin clots
Clots containing 2.5 mg/ml fibrin and the indicated additives were prepared, and their rigidity was evaluated in an oscillation rheometer as described under “Experimental
Procedures.” The values of the storagemodulus (G), the lossmodulus (G), and the loss tangent (tanG/G) were determined after 15min of clotting when they reached
a plateau, whereas the critical shear stress 0 was determined by extrapolation of the fall in viscosity to 0 as illustrated in Fig. 3. Mean and S.D. of three measurements are
shown. Pa, pascals.
Additive
None
50 g/ml
DNA
100 g/ml
DNA
300 g/ml
histone
300 g/ml histone
100 g/ml DNA
G (Pa) 61.79 (13.57) 41.07 (7.29)a 32.42 (2.53)a 67.13 (5.42) 82.06 (5.81)a
G (Pa) 4.03 (1.12) 2.75 (0.42)a 2.06 (0.35)a 7.70 (0.21)a 9.46 (0.38)a
G/G 0.063 (0.019) 0.065 (0.014) 0.063 (0.010) 0.115 (0.008)a 0.115 (0.008)a
0 (Pa) 147.9 (15.8) 79.6 (16.2)a 51.9 (5.9)a 270.4 (15.5)a 370.8 (9.3)a
a p 0.05 according to Kolmogorov-Smirnov test in comparison with pure fibrin.
FIGURE 4. Effect of DNA and histones included within fibrin clots on clotting and lysis profiles. A shows the effects of 0 (circles), 0.03 (squares), 0.13
(triangles), and 0.5 mg/ml (diamonds) DNA on clotting and lysis in the absence of histones. B shows the effects of 0 (circles), 0.04 (squares), 0.33 (triangles), and
1mg/ml histones (diamonds) in the absence of DNA. C shows the same range of histones as in B but in the presence of 0.03mg/ml DNA. In all cases, only every
tenth point is shown for clarity
FIGURE 5. Effects of DNA and histones on appearance of fibrin clots and
rates of lysis. Clot lysis was monitored in the presence of (final concentra-
tions) 1.4 mg/ml fibrinogen and 200 nM plasminogen clotted with 30 nM
thrombin in the presence of 0.2 nM tPA. Tubes in positions 1–5 have the fol-
lowing additions: none, 50 g/ml histones, 70 g/ml DNA, DNA histones,
DNA histones 5 units/ml DNase I, respectively. In A, the DNase was sep-
arated from the DNA until clotting was initiated, and in B, the DNA solution
was pretreated with DNase I for 30 min before clotting. The reaction was
monitored for 3 h duringwhich 2000 pictureswere taken to forma time lapse
video (supplemental Videos 1 and 2). The images shown here were selected
at the times given to illustrate significant stages of the reaction.
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DNA and histones with fibrin degradation products using ITC.
These studies, summarized in Fig. 7, clearly showed that FDPs
bind to both DNA (Kd  136.1 nM) and histones (Kd  190.7
nM) with higher affinity than with fibrinogen and plasminogen
(Table 3). The size of the binding site in the DNA correlated
with the size of the interacting ligand; fibrinogen required the
largest binding site (2146 nucleotides), and plasminogen
required the smallest binding site (682 nucleotides). Further
studies (not shown) indicated that only larger FDPswithmolec-
ular masses	150 kDa demonstrated this high affinity binding,
whereas smaller FDPs or fibrinogen did not.
Heparin is another highly negative charged molecule like
DNA andmay be able to disrupt DNA-histone complexes. The
effects of adding heparin in the microtiter plate system used in
Fig. 4 are shown in Fig. 8. Fig. 8A confirms that there is an effect
of DNA and histones on fibrin structure where clots are formed
with a range of histones with constant DNA becausemaximum
absorbance (related to fibrin fiber thickness) increases with
increasing histones in the presence of DNA. If heparin is pres-
ent, maximum clot absorbance is reduced, and the effect of
histones and DNA is nullified. The effect of heparin on fibrin
lysis is more complicated in the presence of DNA and histones.
Although increasing heparin appears to have only a small effect
on time to 50% lysis in the absence of histones, there is a major
effect of heparin whenDNA and histones are both present. The
plots in Fig. 8, B–F, like those inA, are consistent with a pattern
where heparin can displace DNA from the complex with his-
tones and higher concentrations of heparin are required as the
histone concentration is increased. However, the obvious peak
in lysis times seen at an optimum heparin concentration in Fig.
8, B–F, suggests that there is a heparin-histone-DNA ternary
complex that has a major effect on clot structure and lysis.
DISCUSSION
Based on the demonstration of neutrophil elastase-specific
fibrin degradation products, we have recently provided ex vivo
evidence for the proteolytic contribution of neutrophils to
fibrinolysis in arterial thrombi (28). A different aspect of leuko-
cyte functionality in thrombolysis is suggested by the presence
of DNA and histones in clots from arteries revealed by the pres-
ent study (Fig. 1). These observations on arterial clots add to
previous work on the contribution of DNA and histones to the
FIGURE 6. Confocal microscopy studies using tPA-GFP and red fluores-
cent fibrin after 25 min of fibrinolysis. Each column of micrographs from
left to right shows green tPA-GFP fluorescence, red Alexa Fluor 546-conju-
gated fibrin fluorescence, and the merged image. The first row shows the
accumulation of fibrin aggregates that co-localize with tPA-GFP. The second
rowwith the addition of 70g/ml DNA shows less fibrin aggregate forma-
tion but a diffuse fibrin clot that remains behind the advancing tPA-GFP
front. The lower two rows where clots contain 50 g/ml histones and 50
g/ml histones  70 g/ml DNA, respectively, demonstrate reduced for-
mation of fibrin aggregates within fibrin and less binding of tPA-GFP. The
numbers in the last column indicate the relative distance for penetration of
tPA-GFP in the clot at 25min (themeanvalue for pure fibrin is 1,meanandS.E.
from at least six samples, p 0.05 for all additives according to the Kolmogo-
rov-Smirnov test in comparison with pure fibrin). Scale bars, 20 m.
FIGURE 7. Binding of FDPs andDNA studied using ITC. The cell (1.43ml) of
the titration calorimeterwas filledwith0.5mg/mlDNA, 25 successive aliquots
(10 l each) of 6 M FDPs were injected into the cell at 25 °C, and the heat
increments of each addition (rawdifferential power (DP)) weremeasured (top
panel). The base line-corrected, peak-integrated, and concentration-normal-
ized enthalpy changes (
QN; bottom panel, squares) were evaluated accord-
ing to the single site algorithm, and the best fitting binding isotherm is
shown. The inset shows a non-reducing SDS-PAGE gel of typical FDP prepa-
rations consisting of high molecular weight fibrin fragments (binding) and
lowmolecular weight fibrin fragments (non-binding).
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pathogenesis of deep vein thrombosis in animal models, for
example baboons (5) and mice (13), as well as other conditions
such as sepsis (29) and inflammatory and autoimmune diseases
(30). The influence of DNA and histones on arterial thrombi
warranted further investigation, and our results presented
above suggest that DNA, histones, DNA histones, and hepa-
rin can have different, sometimes opposing, effects, which are
now considered below in turn.
Histones—Histones appear to have a significant effect on clot
structure as shown in Table 1 and suggested in Figs. 2, 4, and 8.
The trend is for more opaque fibrin, correlating with thicker
fibrin fibers. As illustrated in Fig. 3, the impact is to provide a
more robust clot structure in line with earlier data from pure
fibrin clots (21) in which changes in fiber diameter had a signif-
icant impact on the G/G ratio (dissipated/stored energy in
deformation; Table 2). The fibrinolysis data for time to clot
collapse (results summarized in Fig. 5) and confocal micros-
copy studies in Fig. 6 suggest that the activity of tPAmay be up
to 50% higher in the presence of 50g/ml histones. Themicro-
titer plate system (Fig. 4) provided data that histones appear to
delay lysis at the higher concentrations approaching 1 mg/ml.
However, at lower concentrations, the relative rate of fibrinol-
ysis is higher in the presence of histones if we take into account
the higher initial peak absorbance and time to lysis. These
results agree with previous observations that thicker fibers pro-
mote more rapid clot lysis (31). There is evidence from the ITC
TABLE 3
Binding data from isothermal titration calorimetry
The intermolecular interactions of the indicated ligands were measured as described under “Experimental Procedures” and illustrated in Fig. 7. Fg, fibrinogen; Plg,
plasminogen;N, size of binding site (in number of nucleotides whenDNA is the binding partner or number ofmolecules when histone is used);Kd, dissociation equilibrium
constant; 
H, enthalpy change. Mean and S.D. of at least four measurements are shown.
FDP/DNA FDP/histone Fg/DNA Plg/DNA
Mean S.D. Mean S.D. Mean S.D. Mean S.D.
N 1315.8 136.3 1.6 0.5 2145.9 1903.0 682.0 110.9
Kd (nM) 136.1 111.7 190.7 91.7 534.3 52.8 524.1 72.7

H (kcal/mol) 239.5 28.8 12.8 2.9 1116.3 1874.4 153.0 135.6
FIGURE8.HeparindisplacesDNA in thehistone-DNAcomplex.A shows theeffect ofunfractionatedheparin concentrationonmaximumclot absorbance for
clots containing 0.015 mg/ml DNA and 0 (crosses), 0.02 (circles), 0.05 (diamonds), 0.1 (triangles), 0.25 (squares), and 0.3 mg/ml (inverted triangles) histone. B–F
showtheeffects of increasingunfractionatedheparin concentrationon the times to50% lysis (notwith same rangesbut all in seconds) in clots containing0.015
mg/mlDNAand the same rangeofhistoneconcentrations as inA. In all cases, the crosses showtheeffect of heparin alone (lysis timeswithDNAbutnohistones),
and the x axis is heparin concentration (log scale IU/ml in reaction mixture).
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studies (Fig. 7) that histones can bind FDPs, and this may
account for inhibition of lysis at higher histone concentrations
(	110 g/ml).
DNA—In contrast to histones, the effects of DNA on clot
structure are minor (Table 1 and Figs. 2 and 4). However, rhe-
ology data suggest that clots containingDNAwere less stable in
response tomechanical shear forces, had reduced stiffness (G),
and weremore able to dissipate energy in response to deforma-
tion (G), suggesting “weak, floppy” clots (Table 2). The SAXS
data (Fig. 2) reveal the structural background of these effects:
disrupted longitudinal alignment of themonomers (loss of Peak
2; supplemental table) and preserved protofibril-to-protofibril
distance (no change in Peak 3; supplemental table). Fibrinolysis
may also be inhibited in these clots according to data presented
in Fig. 4 and from the clot collapse assay, but here it may be
important to differentiate between fibrin lysis and plasminogen
activation in clots that incorporateDNA. Previouswork involv-
ing binding studies and enzyme assays has shown thatDNAand
oligonucleotides can promote plasminogen activation by tPA
and urokinase-type plasminogen activator with both Glu- and
Lys-plasminogen (32). The mechanism of stimulation is pro-
posed to be via template formation between plasminogen, acti-
vator, and DNA such that the apparent Km for plasminogen
reaction with tPA or to a lesser extent urokinase-type plasmin-
ogen activator is reduced. Potentially significant increases up to
480- or 17-fold in stimulation of kcat/Km for plasminogen acti-
vation by tPA and urokinase-type plasminogen activator,
respectively, were found, but the interaction was also found to
be dependent on ionic strength. It was proposed that DNA and
fibrin compete to bind plasminogen and activator (32). We
have made similar observations using an assay system in which
plasminogen activation is measured with a plasmin-specific
chromogenic substrate in the presence of fibrin (33). However,
fibrinolysis assays do not show any increased lysis due to DNA
but rather delayed clot dissolution. Significantly, it appears
from the confocal microscopy studies in Fig. 6 (second row)
coupled with the ITC data shown in Fig. 7 and observations in
Fig. 5 that DNAmay bind to large FDPs and effectively hold the
network together. Further digestion of large FDPs to lower
molecular weight forms is then required to achieve complete
clot dissolution.
DNA  Histones—The combination of DNA with histones
provides effects that are greater than either component alone.
Structural changes seen with histones are retained with the
addition of DNA as shown in Table 1 and SAXS studies (Fig. 2)
for example. Clot rigidity is enhanced in rheology studies (Fig.
3) by the addition ofDNA to histones as evidenced by improved
stability, rigidity, an increase in loss modulus G, and a signifi-
cant impact on the G/G ratio (dissipated/stored energy in
deformation; Table 2). Increased fiber diameter has been iden-
tified as a significant factor in increasing clot stability and net-
work stiffness (21), and it has also been proposed that clot rigid-
ity might be a predisposing factor for increased myocardial
infarction (34). The striking changes seen in Fig. 4C are imme-
diately visually apparent in Fig. 5, tubes 4 and 5. Thus, the incor-
poration of DNA and histones into fibrin clots extended the
time to lysis by tPA by many hours. Nevertheless, close inspec-
tion of these tubes suggests that the onset of fibrinolysis was
rapid, and the trapped bubbles monitored in Fig. 5 began to
move early in the lysis process before those in the tubes con-
taining DNA or histones alone, suggesting efficient plasmino-
gen activation and fibrin breakdown. Furthermore, confocal
studies (Fig. 6) also suggest that histones and DNA together do
not hinder the rate of fibrin lysis, the background of which can
be identified in the decreased fiber density (loss of Peak 3; Fig. 2
and supplemental table). Taken together with the ITC data that
indicate that both DNA and histones may bind FDPs, it may be
proposed that the slow breakdown seen in Fig. 4C and Fig. 5,
tube 4, is due to a long lived network of DNA, FDPs, and his-
tones. That DNA is critical in this proposed network is demon-
strated by tube 5, which contained DNase I either added during
clot formation (Fig. 5A) or mixed with DNA 30 min prior to
clotting (Fig. 5B). Close inspection of lysis in supplemental Vid-
eos 1 and 2 shows that the DNase causes a different pattern of
breakdown of the network in Fig. 5A whereby large fragments
of fibrin can be seen raining down (without DNase, the fibrin
network simply fades). In Fig. 5B, tube 5, the DNase pretreat-
ment prevents formation of the heterogeneous clot structure
seen in tube 4, and lysis is efficient and only slightly prolonged
relative to control clots with no DNA or histones. Thus, DNase
is an effective fibrinolytic agent in this system in combination
with tPA.
Heparin—Heparin has been suggested as a potential treat-
ment for sepsis as it can potentially bind to and neutralize his-
tones in circulation, and heparin is known to interfere with
formation of NETs (5, 35). Non-anticoagulant heparins have
been explored, and evidence has been presented that they act in
more complexways than simply binding positively charged his-
tones (3, 36). In the current study, unfractionated heparin was
included in clot lysis experiments to investigate its effects on
clot structure and lysis. A summary of results is presented in
Fig. 8. Both clotting and lysis were affected, indicating that hep-
arin, histones, andDNA canmodify fibrin formation and struc-
ture. Over a range of heparin concentrations in a system con-
taining DNA and histones, there was a pronounced peak in clot
lysis time at a heparin concentration that was dependent on the
histone concentration. This pattern of response where there is
an optimumheparin concentration and a bell-shaped profile on
a log heparin concentration scale suggests a template mecha-
nism and formation of a heparin-histone-DNA trimeric com-
plex, which has a profound impact on clot behavior. As the
heparin concentration is increased, the data suggest that DNA
is displaced, and the histone-heparin dimer complex predomi-
nates. The displacement of DNA is supported by the SAXS data
(Fig. 2). The nanostructural pattern of the quaternary fibrin-
DNA-histone-heparin complex resembles that of the fibrin-
DNA clots but not of the pure fibrin clots (supplemental table).
The proposition that the heparin-histone-DNA trimer may
have distinct and significant effects on clot structure and lysis
requires further investigation if heparin and heparin-like mol-
ecules are to be used in the clinical setting of sepsis and other
situations where DNA and histones are present in the
circulation.
In Vivo Implications—The diverse methods utilized in the
current work mostly require purified components in relatively
simple systems, and obviously caution is required when extrap-
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olating to the in vivo situation. Nevertheless, these data add to
previouswork implicatingDNAandhistones in disturbances in
coagulation and promotion of deep vein thrombosis (3, 5, 36).
We have extended these studies to include arterial clots and
now focus on fibrinolysis. These earlier studies involved his-
tones within the same concentration range used in the present
study (around 40 g/ml for example (3, 36)), and concentra-
tions up to 70 g/ml have been measured in baboon models of
sepsis (29). It is difficult to estimate the amounts of DNA that
might be found in venous or arterial blood clots, but very high
local concentrations around dead cells are likely as observed
previously (5). The heterogeneous distribution ofDNAandhis-
tones observed in arterial clots shown in Fig. 1 suggests that it
will be difficult to predict how they affect clot stability and lysis
in vivo. In addition to situations where NET formation is likely,
DNAandhistonesmay accumulate in the vicinity of atheroscle-
rotic plaques, which contain dead cells. Thrombosis is believed
to occur here after necrotic core expansion causesweakening of
the atheroma cap to generate thrombogenic debris (37).
Inflammatory signals may also recruit additional leukocytes to
blood clots, providing an increased pool of DNA and histones
(38). We propose that DNA release may result in weakened
clots more prone to embolize, whereas histones might
strengthen clot structure. DNAandhistonesmay enhance plas-
minogen activation, but the most important observation in the
present study is the slow breakdown of fibrin clots containing
DNA  histones, which appear to stabilize the network by
binding large FDPs. We find that heparin can counter the
effects of DNA in clot lysis, but further work is required to
investigate the activity of DNA-histone-heparin complexes.
Prolonged clot lysis in the presence of histonesDNAmay be
reversed by DNase, providing a rationale for the secretion of
streptodornase along with streptokinase by streptococci as
mentioned above. If arterial clots do contain significant levels of
histones and DNA derived from atheroma or released by apo-
ptotic cells within the clots it raises the prospect that adding
DNase to plasminogen activators used for thrombolytic treat-
ment may lead to improved therapeutic outcomes.
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